Valuation ResMed, Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:02 05/12/2025 GMT			5-day change	1st Jan Change
256.55 ^USD	+2.00%		+0.28%	+12.18%

12-04	Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	MT
12-02	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	35,903	30,691	32,133	28,117	37,762	37,393	-	-
Change	-	-14.52%	4.7%	-12.5%	34.31%	-0.98%	-	-
Enterprise Value (EV) ¹	36,263	31,192	33,346	28,585	37,221	36,163	35,295	34,179
Change	-	-13.98%	6.9%	-14.28%	30.21%	-2.84%	-2.4%	-3.16%
P/E ratio	76.1x	39.6x	35.9x	27.7x	27.1x	24.5x	22.1x	20.1x
PBR	12.4x	9.35x	7.76x	5.78x	6.33x	5.47x	4.73x	4.28x
PEG	-	0.6x	2.4x	2x	0.7x	2.4x	2x	2.04x
Capitalization / Revenue	11.2x	8.58x	7.61x	6x	7.34x	6.67x	6.21x	5.8x
EV / Revenue	11.3x	8.72x	7.9x	6.1x	7.23x	6.45x	5.86x	5.3x
EV / EBITDA	33.8x	26.8x	25.3x	18.1x	19.8x	16.7x	15x	13.4x
EV / EBIT	40.1x	31.2x	27.2x	19.3x	21.1x	17.8x	16x	14.3x
EV / FCF	57.2x	144x	58.1x	22x	22.4x	23x	20.8x	18.7x
FCF Yield	1.75%	0.69%	1.72%	4.55%	4.46%	4.36%	4.8%	5.35%
Dividend per Share ²	1.56	1.68	1.8	1.92	-	2.418	2.661	2.895
Rate of return	0.63%	0.8%	0.82%	1%	-	0.94%	1.04%	1.13%
EPS ²	3.24	5.3	6.09	6.92	9.51	10.49	11.63	12.77
Distribution rate	48.1%	31.7%	29.6%	27.7%	-	23.1%	22.9%	22.7%
Net sales ¹	3,197	3,578	4,223	4,685	5,146	5,602	6,020	6,443
EBITDA ¹	1,074	1,162	1,317	1,576	1,884	2,166	2,354	2,547
EBIT ¹	903.7	1,000	1,224	1,478	1,763	2,027	2,209	2,386
Net income ¹	474.5	779.4	897.6	1,021	1,401	1,535	1,707	1,864
Net Debt ¹	360.1	501.5	1,213	468.9	-541.2	-1,230	-2,098	-3,214
Reference price ²	246.52	209.63	218.50	191.42	258.00	256.55	256.55	256.55
Nbr of stocks (in thousands)	145,640	146,405	147,062	146,884	146,365	145,753	-	-
Announcement Date	05/08/21	11/08/22	03/08/23	01/08/24	31/07/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
RESMED, INC.	24.46x	6.45x	16.7x	0.94%	37.39B
THERMO FISHER SCIENTIFIC, INC.	32.09x	5.49x	21.76x	0.29%	215B
INTUITIVE SURGICAL, INC.	76.29x	20.04x	46.79x	-.--%	204B
DANAHER CORPORATION	43.49x	7.06x	22.81x	0.55%	160B
BOSTON SCIENTIFIC CORPORATION	47.22x	7.64x	24.94x	-.--%	145B
SIEMENS HEALTHINEERS AG	20.67x	2.44x	11.86x	2.35%	56.48B
EDWARDS LIFESCIENCES CORPORATION	37.49x	7.75x	25.65x	-.--%	50.02B
AGILENT TECHNOLOGIES, INC.	32.61x	6.19x	22.06x	0.67%	41.18B
GE HEALTHCARE TECHNOLOGIES INC.	18.66x	2.15x	12.09x	0.17%	38.93B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	25.58x	6.55x	18.7x	2.6%	34.62B
Average	35.86x	7.18x	22.34x	0.76%	98.21B
Weighted average by Cap.	43.94x	9.00x	26.55x	0.45%